Acutus Medical
Provides patient-focused solutions for the electrophysiology community that help people live better lives.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $35.0m | Post IPO Debt | |
| Total Funding | 000k | ||
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 31 % | 198 % | 104 % | (5 %) | (56 %) | 181 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1872 %) | (2361 %) | (1027 %) | (631 %) | (509 %) | (240 %) | (36 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (2212 %) | (3422 %) | (1205 %) | (682 %) | (242 %) | (1140 %) | (47 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 881 % | 1341 % | 395 % | 212 % | 172 % | 49 % | - |
Source: Company filings or news article
Related Content
Acutus Medical is a pioneering company in the healthcare technology sector, specifically focusing on the treatment of complex cardiac arrhythmias. The company has developed a groundbreaking technology that allows physicians to visualize the electrical activity within a cardiac chamber in real time. This innovation is particularly significant for patients suffering from atrial arrhythmias, a condition where the heart beats irregularly. Traditional treatment options for these patients have often been slow to advance and have yielded less than satisfactory results.
Acutus Medical's flagship product is its unique imaging and mapping system, which includes a proprietary mapping algorithm known as SuperMap. This system is the first of its kind to offer three distinct mapping modes, enabling physicians to map any heart rhythm quickly and accurately. The SuperMap algorithm allows electrophysiologists—doctors specializing in the electrical functions of the heart—to map multi-circuit, stable rhythms in just three minutes. This rapid and consistent mapping capability is a significant improvement over existing technologies.
The primary clients for Acutus Medical are healthcare providers, particularly hospitals and specialized cardiac centers, and the electrophysiologists who work within these institutions. The company operates in the medical device market, which is a highly specialized and regulated sector.
Acutus Medical's business model revolves around the sale and distribution of its advanced mapping systems and related software. The company generates revenue through the direct sale of these systems, as well as through ongoing service and maintenance contracts. Additionally, Acutus may benefit from recurring revenue streams via software updates and potential licensing agreements.
In summary, Acutus Medical is revolutionizing the treatment of cardiac arrhythmias with its innovative mapping technology, providing significant benefits to both patients and healthcare providers.
Keywords: cardiac arrhythmias, electrophysiologists, mapping system, SuperMap, real-time visualization, healthcare technology, atrial arrhythmias, medical devices, hospitals, innovation.